Filed with the SEC on · Summarized by InvestorsBot
Daniel Patrick O'Day, Gilead Sciences' Chairman and CEO and a director, sold 12,000 shares at $147.72 each for approximately $1.77 million, leaving him with 569,683 shares. He also sold 3,000 shares at $148.63 each for approximately $445,880, leaving him with 566,683 shares; the two sales totaled approximately $2.22 million.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeGilead CEO Daniel O'Day sells $2.2M in stock
Form 4 · Insider Trade · September 2, 2026
Gilead director Anthony Welters sells $2.7M in stock
Form 4 · Insider Trade · August 27, 2026
Gilead chief communications officer sells $3.85M in stock
Form 4 · Insider Trade · August 18, 2026
Gilead reports 10% revenue growth but widens 2026 loss guidance
8-K · August 4, 2026
Gilead CEO Daniel O’Day sells about $2.0M in stock
Form 4 · Insider Trade · August 4, 2026
Gilead filed exhibits re: an acquisition — Agreement & Plan of Merger (dated Feb 22, 2026) among Gilead,…
8-K · February 23, 2026